EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access

Treatment of lacrimal gland adenoid cystic carcinoma: a systematic review and Meta-analysis

Hai-Han Yan, Rui Liu, Nan Wang, Liang-Yuan Xu, Qi-Han Guo, Jing Li, Jian-Min Ma

International Journal of Ophthalmology · 18.01.2024 · 17 (1) · 164-172

DOI: 10.18240/ijo.2024.01.22 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift International Journal of Ophthalmology, erschienen am 18.01.2024. Verfasst von Hai-Han Yan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University; Beijing Ophthalmology & Visual …. Die Arbeit wurde bisher 15-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIM: To evaluate lacrimal gland adenoid cystic carcinoma (LGACC) of prognosis in patients who underwent different treatment regimens. METHODS: We searched PubMed, EMBASE, and the Cochrane Library for studies done on the treatment of LGACC, between January 1987 and April 2022. A Meta-analysis was conducted to pool the 5-year overall survival rate (OR), and the 5-year recurrence rate (RR) and 5-year metastasis rate (MR) were assessed. RESULTS: The 30 studies involved 585 patients were included in the Meta-analysis. The pooled 5-year OR with surgery alone was 50%, the 5-year RR was 63%, and the 5-year MR was 34%. The pooled 5-year OR with surgery and adjuvant radiotherapy combined was 67% (95%CI 61%,73%), the 5-year RR was 41%, and the 5-year MR was 35%. The pooled 5-year OR with surgery and adjuvant chemoradiotherapy combined was 72% (95%CI 59%, 84%), the 5-year RR was 48%, and the 5-year MR was 36%. The pooled 5-year OR with surgery, intra-arterial cytoreductive chemotherapy, and adjuvant chemoradiotherapy combined was 78% (95%CI 68%, 89%), the 5-year RR was 15%, and the 5-year MR was 27%. CONCLUSION: Comprehensive treatment is more effective than surgery alone. Surgery combined with intra-arterial chemotherapy and adjuvant chemoradiotherapy seems to add value to the therapeutic effect of comprehensive treatment of LGACC but further high-quality research is required to validate this.

Schlagwörter

Stichwörter der Autor:innen

Meta-analysisadenoid cystic carcinomalacrimal gland

Autor:innen und Institutionen

  • Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University; Beijing Ophthalmology & Visual Sciences Key Laboratory, Beijing 100730, China.

Zitieren

APA

Yan, H. H., Liu, R., Wang, N., Xu, L. Y., Guo, Q. H., Li, J., & Ma, J. M. (2024). Treatment of lacrimal gland adenoid cystic carcinoma: a systematic review and Meta-analysis. International Journal of Ophthalmology, 17(1), 164-172. https://doi.org/10.18240/ijo.2024.01.22

Vancouver

Yan HH, Liu R, Wang N, Xu LY, Guo QH, Li J, et al. Treatment of lacrimal gland adenoid cystic carcinoma: a systematic review and Meta-analysis. International Journal of Ophthalmology. 2024;17(1):164-172. doi:10.18240/ijo.2024.01.22

BibTeX
@article{Yan2024,
  author = {Yan, Hai-Han and Liu, Rui and Wang, Nan and Xu, Liang-Yuan and Guo, Qi-Han and Li, Jing and Ma, Jian-Min},
  title = {Treatment of lacrimal gland adenoid cystic carcinoma: a systematic review and Meta-analysis},
  journal = {International Journal of Ophthalmology},
  year = {2024},
  volume = {17},
  number = {1},
  pages = {164--172},
  doi = {10.18240/ijo.2024.01.22}
}
Kostenlos starten →